AlphaMol Science LTD

Startup

AlphaMol combines computational biology and in-house cutting-edged biotechnology, aiming at building up a complete pipeline to advance modern new drug discovery and drug design in an ultimately efficient way. Currently, AlphaMol has advanced first-in-class preclinical candidates within 9 months which usually takes 5-7 years to achieve via traditional way; several pipelines are now in the lead optimization stages which usually take 2-3 years to achieve.